Literature DB >> 34162733

Integrative Cistromic and Transcriptomic Analyses Identify CREB Target Genes in Cystic Renal Epithelial Cells.

Zhiheng Liu1,2, Yunjing Liu1, Lin Dang1, Meijuan Geng1, Yongzhan Sun1, Yi Lu1, Zhongze Fang2, Hui Xiong3, Yupeng Chen4.   

Abstract

BACKGROUND: Genome-wide mapping of transcription factor (TF) binding sites is essential to identify a TF's direct target genes in kidney development and diseases. However, due to the cellular complexity of the kidney and limited numbers of a given cell type, it has been challenging to determine the binding sites of a TF in vivo. cAMP response element-binding protein (CREB) is phosphorylated and hyperactive in autosomal dominant polycystic kidney disease (ADPKD). We focus on CREB as an example to profile genomic loci bound by a TF and to identify its target genes using low numbers of specific kidney cells.
METHODS: Cleavage under targets and release using nuclease (CUT&RUN) assays were performed with Dolichos biflorus agglutinin (DBA)-positive tubular epithelial cells from normal and ADPKD mouse kidneys. Pharmacologic inhibition of CREB with 666-15 and genetic inhibition with A-CREB were undertaken using ADPKD mouse models.
RESULTS: CUT&RUN to profile genome-wide distribution of phosphorylated CREB (p-CREB) indicated correlation of p-CREB binding with active histone modifications (H3K4me3 and H3K27ac) in cystic epithelial cells. Integrative analysis with CUT&RUN and RNA-sequencing revealed CREB direct targets, including genes involved in ribosome biogenesis and protein synthesis. Pharmacologic and genetic inhibition of CREB suppressed cyst growth in ADPKD mouse models.
CONCLUSIONS: CREB promotes cystogenesis by activating ribosome biogenesis genes. CUT&RUN, coupled with transcriptomic analysis, enables interrogation of TF binding and identification of direct TF targets from a low number of specific kidney cells.
Copyright © 2021 by the American Society of Nephrology.

Entities:  

Keywords:  ADPKD; CREB; CUT&RUN; cAMP; kidney diseases; transcription factors

Mesh:

Substances:

Year:  2021        PMID: 34162733      PMCID: PMC8722786          DOI: 10.1681/ASN.2021010101

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   14.978


  55 in total

Review 1.  Vasopressin and disruption of calcium signalling in polycystic kidney disease.

Authors:  Fouad T Chebib; Caroline R Sussman; Xiaofang Wang; Peter C Harris; Vicente E Torres
Journal:  Nat Rev Nephrol       Date:  2015-04-14       Impact factor: 28.314

Review 2.  Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease.

Authors:  Peter C Harris; Vicente E Torres
Journal:  J Clin Invest       Date:  2014-06-02       Impact factor: 14.808

3.  Targeted in situ genome-wide profiling with high efficiency for low cell numbers.

Authors:  Peter J Skene; Jorja G Henikoff; Steven Henikoff
Journal:  Nat Protoc       Date:  2018-04-12       Impact factor: 13.491

Review 4.  Ribosome biogenesis in cancer: new players and therapeutic avenues.

Authors:  Joffrey Pelletier; George Thomas; Siniša Volarević
Journal:  Nat Rev Cancer       Date:  2017-12-01       Impact factor: 60.716

Review 5.  The cell biology of polycystic kidney disease.

Authors:  Hannah C Chapin; Michael J Caplan
Journal:  J Cell Biol       Date:  2010-11-15       Impact factor: 10.539

6.  mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer.

Authors:  Amaia Zabala-Letona; Amaia Arruabarrena-Aristorena; Natalia Martín-Martín; Sonia Fernandez-Ruiz; James D Sutherland; Michelle Clasquin; Julen Tomas-Cortazar; Jose Jimenez; Ines Torres; Phong Quang; Pilar Ximenez-Embun; Ruzica Bago; Aitziber Ugalde-Olano; Ana Loizaga-Iriarte; Isabel Lacasa-Viscasillas; Miguel Unda; Verónica Torrano; Diana Cabrera; Sebastiaan M van Liempd; Ylenia Cendon; Elena Castro; Stuart Murray; Ajinkya Revandkar; Andrea Alimonti; Yinan Zhang; Amelia Barnett; Gina Lein; David Pirman; Ana R Cortazar; Leire Arreal; Ludmila Prudkin; Ianire Astobiza; Lorea Valcarcel-Jimenez; Patricia Zuñiga-García; Itziar Fernandez-Dominguez; Marco Piva; Alfredo Caro-Maldonado; Pilar Sánchez-Mosquera; Mireia Castillo-Martín; Violeta Serra; Naiara Beraza; Antonio Gentilella; George Thomas; Mikel Azkargorta; Felix Elortza; Rosa Farràs; David Olmos; Alejo Efeyan; Juan Anguita; Javier Muñoz; Juan M Falcón-Pérez; Rosa Barrio; Teresa Macarulla; Jose M Mato; Maria L Martinez-Chantar; Carlos Cordon-Cardo; Ana M Aransay; Kevin Marks; José Baselga; Josep Tabernero; Paolo Nuciforo; Brendan D Manning; Katya Marjon; Arkaitz Carracedo
Journal:  Nature       Date:  2017-06-28       Impact factor: 49.962

7.  A single-nucleus RNA-sequencing pipeline to decipher the molecular anatomy and pathophysiology of human kidneys.

Authors:  Blue B Lake; Song Chen; Masato Hoshi; Nongluk Plongthongkum; Diane Salamon; Amanda Knoten; Anitha Vijayan; Ramakrishna Venkatesh; Eric H Kim; Derek Gao; Joseph Gaut; Kun Zhang; Sanjay Jain
Journal:  Nat Commun       Date:  2019-06-27       Impact factor: 14.919

8.  Informatics-guided drug repurposing for Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Authors:  Anna A Kiseleva; Erica A Golemis
Journal:  EBioMedicine       Date:  2020-01-22       Impact factor: 8.143

Review 9.  What turns CREB on? And off? And why does it matter?

Authors:  André Steven; Michael Friedrich; Paul Jank; Nadine Heimer; Jan Budczies; Carsten Denkert; Barbara Seliger
Journal:  Cell Mol Life Sci       Date:  2020-04-28       Impact factor: 9.261

10.  Conserved and Divergent Features of Human and Mouse Kidney Organogenesis.

Authors:  Nils O Lindström; Jill A McMahon; Jinjin Guo; Tracy Tran; Qiuyu Guo; Elisabeth Rutledge; Riana K Parvez; Gohar Saribekyan; Robert E Schuler; Christopher Liao; Albert D Kim; Ahmed Abdelhalim; Seth W Ruffins; Matthew E Thornton; Laurence Baskin; Brendan Grubbs; Carl Kesselman; Andrew P McMahon
Journal:  J Am Soc Nephrol       Date:  2018-02-15       Impact factor: 10.121

View more
  1 in total

Review 1.  Emerging therapies for autosomal dominant polycystic kidney disease with a focus on cAMP signaling.

Authors:  Xia Zhou; Vicente E Torres
Journal:  Front Mol Biosci       Date:  2022-09-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.